This is the authors' abstract. We don't add key points for this paper.
. Accordingly, the findings discussed indicated that biological larvicides and genetic engineering technologies constitute noteworthy alternatives of future mosquito-borne arbovirus disease control efforts.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: